Business & Finance
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
31 October 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Friday it has been awarded a new and expanded procurement framework contract by the European Commission thr...
Perrigo to pay quarterly dividend of USD0.290 per share
30 October 2025 - Perrigo Company plc (NYSE: PRGO), an American-Irish global provider of consumer health products, on Wednesday announced a quarterly dividend of USD0.290 per share.This amount is unch...
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
29 October 2025 - Life science and clinical research company Thermo Fisher Scientific Inc (NYSE:TMO) on Wednesday announced an agreement to acquire Clario Holdings Inc, a provider of endpoint data sol...
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
27 October 2025 - Nanoform Finland Plc (Nasdaq First North Growth Market: NANOFH, NANOFS), a medicine performance-enhancing company, on Monday announced a partnership with specialty pharma company Rev...
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
21 October 2025 - Cumberland Pharmaceuticals Inc (Nasdaq:CPIX), a US-based specialty pharmaceutical company, announced on Monday that it has entered into strategic arrangements with RedHill Biopharma ...
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
13 October 2025 - IP Group plc (LSE: IPO), an investor in breakthrough science and innovation companies, on Monday outlined potential future royalty income linked to obesity drug candidates developed ...